Disclaimer: All content on this site — including company research, ratings, price targets, and market commentary — is generated automatically by artificial intelligence and may or may not have been reviewed, fact-checked, or verified by any human analyst, editor, or financial professional. No representation or warranty, express or implied, is made as to the accuracy, completeness, timeliness, or reliability of any information presented. StockWatch.report and its operators accept no responsibility or liability whatsoever for any loss or damage arising from reliance on this content. Nothing on this site constitutes investment, financial, legal, or tax advice, or a recommendation or solicitation to buy or sell any security. This content is provided for informational purposes only and must not be used as the basis for any investment decision. The operators of StockWatch.report and their affiliates may hold long or short positions in securities discussed on this site at any time. You are solely responsible for your own investment decisions and should consult a qualified, licensed financial professional before acting on any information presented here. Use of this site is governed by, and subject to, our Terms and Conditions.
CAG ConAgra Brands, Inc.CAG: ConAgra Brands Reports FY2026 Full-Year Results With $12.05B in Revenue and $0.72 Diluted EPS
30 Sep 2026, 10:45 AM ETJBL Jabil Inc.JBL: Jabil Reports Q3 FY2026 Earnings With $21.55B Revenue and $439M Net Income
30 Sep 2026, 10:14 AM ETCBOE Cboe Global Markets, Inc.CBOE: Cboe Global Markets Files 8-K Disclosing New Material Agreement and Q2 2026 Financial Results
30 Sep 2026, 10:10 AM ETMDB MongoDB, Inc.MDB: MongoDB Reports Q2 FY2027 Revenue of $1.14 Billion, Widens Operating Loss
30 Sep 2026, 10:10 AM ETMAT Mattel, Inc.MAT: Mattel Discloses Leadership Change Alongside Q2 FY2026 Results Showing $40M Net Loss
30 Sep 2026, 9:44 AM ETCALM Cal-Maine Foods, Inc.CALM: Cal-Maine Foods Posts Q1 FY2027 EPS of $4.12 on $922.6M in Revenue
30 Sep 2026, 9:42 AM ETMRNA Moderna, Inc.MRNA: Moderna Files 8-K Disclosing Executive Change and Q2 FY2026 Financial Results Amid Deepening Losses
30 Sep 2026, 9:42 AM ETVKTX Viking Therapeutics, Inc.VKTX: Viking Therapeutics Enters New Material Agreement, Files 8-K Disclosing Contract and Debt Obligation
29 Sep 2026, 3:24 PM ETRNG Ringcentral, Inc.RNG: RingCentral Files 8-K Disclosing Q2 FY2026 Financials — Net Loss Persists Despite Operating Profit
29 Sep 2026, 2:22 PM ETAIR AAR Corp.AIR: AAR Corp. Reports Q1 FY2027 Earnings of $0.95 Diluted EPS, Shares Fall 6.4%
29 Sep 2026, 1:20 PM ET